Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry (Q41616285)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 1997

Pharmacologic Management of Supraventricular Tachycardias in Children

Language	Label	Description	Also known as
English	Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry	scientific article published on October 1997	Pharmacologic Management of Supraventricular Tachycardias in Children

Statements

scholarly article

1 reference

Europe PubMed Central

5 October 2017

1 reference

Europe PubMed Central

Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry (English)

1 reference

Europe PubMed Central

5 October 2017

Parkinson's disease

1 reference

based on heuristic

inferred from title

author name string

S A Luedtke

1

1 reference

Europe PubMed Central

5 October 2017

R J Kuhn

2

1 reference

Europe PubMed Central

5 October 2017

F M McCaffrey

3

1 reference

Europe PubMed Central

5 October 2017

language of work or name

0 references

publication date

1 October 1997

1 reference

Europe PubMed Central

5 October 2017

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

5 October 2017

31

1 reference

Europe PubMed Central

5 October 2017

1227-1243

1 reference

Europe PubMed Central

5 October 2017

10

1 reference

Europe PubMed Central

5 October 2017

Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Cardiac arrhythmias in childhood. Diagnostic considerations and treatment

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Evaluation and management of supraventricular tachycardia in children

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Supraventricular tachycardia: diagnosis and current acute management

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Management of infants, children, and adolescents with paroxysmal supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Usefulness of adenosine for arrhythmias in infants and children

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Cardiovascular collapse after verapamil in supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Effect of drugs in the Wolff-Parkinson-White syndrome. Importance of initial length of effective refractory period of the accessory pathway

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Effect of Digitalis on Atrioventricular Conduction and Circus-Movement Tachycardias in Patients with Wolff-Parkinson-White Syndrome

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Ventricular fibrillation associated with use of digitalis in a newborn infant with Wolff-Parkinson-White syndrome

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Ventricular fibrillation following verapamil in the Wolff-Parkinson-White syndrome

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Treatment of refractory supraventricular arrhythmias with flecainide acetate

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Wolff-Parkinson-White syndrome in infants and children. A long-term follow-up study

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Wolff-Parkinson-White syndrome in children: electrophysiologic and pharmacologic characteristics

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Wolff-Parkinson-White syndrome in the neonate

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Effects of propranolol on anomalous pathway refractoriness and circus movement tachycardias in patients with preexcitation

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Clinical electrophysiological effects of atenolol--a new cardioselective beta-blocking agent

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Effects of lidocaine and propranolol on the normal and anomalous pathways in patients with preexcitation.

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Effect of verapamil in infants with paroxysmal supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Pre-excitation syndrome in infants and children. Effect of digoxin, verapamil, and amiodarone

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Effect of procaine amide, quinidine, and ajmaline in the Wolff-Parkinson-White syndrome

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Oral propafenone therapy for children with arrhythmias: efficacy and adverse effects in midterm follow-up

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Efficacy and safety of intravenous and oral propafenone in pediatric cardiac dysrhythmias

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

The response of paediatric arrhythmias to intravenous and oral flecainide

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Experience with flecainide for the treatment of cardiac arrhythmias in children

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Paediatric use of flecainide in supraventricular tachycardia: clinical efficacy and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Flecainide acetate for treatment of tachyarrhythmias in children: review of world literature on efficacy, safety, and dosing

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Encainide for refractory supraventricular tachycardia in children.

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Amiodarone treatment of critical arrhythmias in children and young adults.

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Intravenous and oral amiodarone for arrhythmias in children

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Use of amiodarone for short-term and adjuvant therapy in young patients

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

New antiarrhythmic drugs in pediatric use: propafenone.

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Acceleration of the ventricular response to atrial flutter by amiodarone in an infant with Wolff-Parkinson-White syndrome

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Efficacy and proarrhythmia of oral sotalol in pediatric patients

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

The effects of propranolol on induction of A-V nodal reentrant paroxysmal tachycardia.

1 reference

https://api.crossref.org/works/10.1177%2F106002809703101016

21 January 2018

Identifiers

10.1177/106002809703101016

1 reference

Europe PubMed Central

5 October 2017

1 reference

Europe PubMed Central

5 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41616285&oldid=1925091894"